Abstract
摘要
相似文献
1
PAF antagonists in asthma.哮喘中的血小板活化因子拮抗剂
Lancet. 1989 Mar 18;1(8638):592-3.
2
[Role of platelet activating factor and its antagonists in bronchial asthma].[血小板活化因子及其拮抗剂在支气管哮喘中的作用]
Rev Pneumol Clin. 1992;48(2):49-57.
3
[PAF receptor antagonist in asthma therapy].
Nihon Rinsho. 1996 Nov;54(11):3056-61.
4
Platelet-activating factor (PAF) and PAF antagonists in asthma.血小板活化因子（PAF）与哮喘中的PAF拮抗剂
Crit Rev Ther Drug Carrier Syst. 1990;7(3):261-73.
5
The therapeutic relevance of PAF antagonists.血小板激活因子拮抗剂的治疗意义。
Agents Actions Suppl. 1989;28:313-29.
6
[Effect of the platelet-activating factor antagonist BN 52063 on exertional asthma].血小板活化因子拮抗剂BN 52063对运动性哮喘的作用
Pneumologie. 1990 Feb;44 Suppl 1:347-8.
7
Pharmacological evaluation of prophylactic anti-asthma drugs by reference to the pathological sequelae of exposure to allergen or platelet activating factor.通过参考接触过敏原或血小板活化因子的病理后遗症对预防性抗哮喘药物进行药理学评估。
Agents Actions Suppl. 1988;23:187-94. doi: 10.1007/978-3-0348-9156-1_13.
8
[The significance of platelet activating factor and its antagonists in bronchial asthma].
Med Klin (Munich). 1989 Jun 15;84(6):286-93.
9
Drugs affecting pulmonary responses to platelet activating factor as novel anti-asthma drugs.影响肺部对血小板活化因子反应的药物作为新型抗哮喘药物
Agents Actions Suppl. 1988;23:173-85. doi: 10.1007/978-3-0348-9156-1_12.
10
From anti-asthma drugs to PAF-acether antagonism and back. Present status.从抗哮喘药物到血小板活化因子拮抗剂，再回归。现状
Biochem Pharmacol. 1989 May 1;38(9):1373-84. doi: 10.1016/0006-2952(89)90175-5.
Zotero 插件